Dorm Room β 2017 Investments
6 investments dated 2017 Β· listed companies and verified rows first Β· show all
BrainSpec develops software for analyzing and visualizing MR spectroscopy (MRS) neuroimaging data, aiming to make a non-invasive "virtual biopsy" available to clinicians and researchers.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBoston, US
Alexandra Zimmerman(Executive Officer, Director)
Co-investorsTechstars
Brooklinen sells bedding products such as sheets, bed bundles, and related home goods directly to consumers online and through physical stores.
ConsumerDirect to ConsumerE-commerceNew York, US
Rich Fulop(Founder)in
BoardAmish Jain(Director)
Co-investorsFirstMark CapitalFreeman SpogliSummit Partners
Healthie provides a software platform for healthcare practitioners including dietitians and life coaches to manage their practices and deliver virtual, recurring care to patients outside traditional hospital settings.
Digital HealthEnterprise SoftwareHealthtechSaaSWellness & FitnessNew York City, US
Cavan Klinsky(Executive Officer, Director)inErica Jain(Executive Officer, Director)in
BoardSean Ammirati(Director)
Co-investorsBirchmere VenturesGreen Egg VenturesGreyMatterLongley CapitalTechstarsVelvet Sea Ventures+2 more
Brooklyn, US
Kristina Budelis(President and Chief Creative Officer)Lisbeth Kaufman(Chief Executive Officer and Secretary)Ken Amarit(Chief Technology Officer)
Co-investorsEntrepreneurs Roundtable Accelerator (ERA)
HealthtechWilmington, US
Christopher Berlind(Executive Officer, Director)David Lindsay, Jr.(Executive Officer, Director)
BoardGary Kurtzman(Director)
CesiumAstro develops AI-enhanced, software-defined communications systems for space, air, and ground domain applications.
AI & Machine LearningData & InfrastructureDeep TechDefense TechSpace TechNew York City, US
Daniel Morozoff(Executive Officer, Director)Joseph Ellis(Executive Officer, Director)
Co-investorsCapital InnovatorsPrefix CapitalR/GA VenturesSamsung NextSocial StartsTechstars
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.